International Clinical Trial: NefXtend-SZ: A Multicenter, Prospective, Observational, Real-World Study Evaluating the Follow-Up Management and Clinical Outcomes in Primary IgA Nephropathy Patients with Persistent Risk of Progression After 9 Months of Treatment with Budesonide Enteric-Coated Capsules

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128539) titled 'NefXtend-SZ: A Multicenter, Prospective, Observational, Real-World Study Evaluating the Follow-Up Management and Clinical Outcomes in Primary IgA Nephropathy Patients with Persistent Risk of Progression After 9 Months of Treatment with Budesonide Enteric-Coated Capsules' on July 22.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Second People's Hospital of Shenzhen

Condition: IgA nephropathy

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2026-07-31

Target Sample Size: Observation group:100;

Countries of Recruitment: China

To know more, visit https://...